ImmusanT, Inc.

ImmusanT, Inc.

ImmusanT, Inc.

Immusan T is a biotechnology company focused on developing a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease.
Founded
2011
Raised
$20M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Undisclosed amount
Undisclosed funding - 2018
JDRF T1D Fund
$20,000,000
Venture capital (Series A) - 2011
Vatera Healthcare Partners
Team Size
2
Employees
Undisclosed funding
PE HUB

ImmusanT rakes in funding

Xconomy

ImmusanT Gets $40M From Arch, Vatera to Continue Celiac Vaccine Quest

Health